WallStreetZenWallStreetZen

NASDAQ: BLFS
Biolife Solutions Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for BLFS

Based on 4 analysts offering 12 month price targets for Biolife Solutions Inc.
Min Forecast
$23.00+74.9%
Avg Forecast
$25.50+93.92%
Max Forecast
$29.00+120.53%

Should I buy or sell BLFS stock?

Based on 4 analysts offering ratings for Biolife Solutions Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BLFS stock forecasts and price targets.

BLFS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Craig-Hallum
Bottom 7%
7
BuyMaintains$23.00+74.90%2023-08-10
TD Cowen
Bottom 7%
7
BuyMaintains$25.00+90.11%2023-08-09
Lake Street
Bottom 4%
4
Strong BuyMaintains$25.00+90.11%2023-08-09
Stephens & Co.
Bottom 9%
9
Strong BuyMaintains$29.00+120.53%2023-07-17

1 of 1

Forecast return on equity

Is BLFS forecast to generate an efficient return?
Company
N/A
Industry
0.57%
Market
28.82%

Forecast return on assets

Is BLFS forecast to generate an efficient return on assets?
Company
N/A
Industry
0.25%

BLFS revenue growth forecast

How is BLFS forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
18.81%
Industry
5.7%
Market
8.15%
BLFS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BLFS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BLFS vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
BLFS$13.15$25.50+93.92%Strong Buy
OSUR$5.65N/AN/A
ATRI$429.25N/AN/A
UTMD$84.28N/AN/A
SMTI$34.01$59.00+73.48%Strong Buy
View Top Medical Stocks

Biolife Solutions Stock Forecast FAQ

Is Biolife Solutions Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: BLFS) stock is to Strong Buy BLFS stock.

Out of 4 analysts, 2 (50%) are recommending BLFS as a Strong Buy, 2 (50%) are recommending BLFS as a Buy, 0 (0%) are recommending BLFS as a Hold, 0 (0%) are recommending BLFS as a Sell, and 0 (0%) are recommending BLFS as a Strong Sell.

If you're new to stock investing, here's how to buy Biolife Solutions stock.

What is BLFS's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: BLFS) forecast ROE is N/A, which is considered weak.

What is BLFS's Price Target?

According to 4 Wall Street analysts that have issued a 1 year BLFS price target, the average BLFS price target is $25.50, with the highest BLFS stock price forecast at $29.00 and the lowest BLFS stock price forecast at $23.00.

On average, Wall Street analysts predict that Biolife Solutions's share price could reach $25.50 by Aug 10, 2024. The average Biolife Solutions stock price prediction forecasts a potential upside of 93.92% from the current BLFS share price of $13.15.

What is BLFS's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: BLFS) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 0.25%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.